- FOUNDED 1991
Overview
The COSA Cancer Pharmacists Group (CPG) is committed to promoting and further developing the role of the pharmacist in cancer services and is the only national multidisciplinary forum for pharmacists working in cancer services in Australia.
A major goal of the CPG is to facilitate training, education and research within both pharmacy and cancer services while ensuring that pharmacists have input into key national policy documents and clinical guidelines.
CPG membership comprises pharmacists practising in a variety of settings including medical oncology, haematology, palliative care and chemotherapy preparation services in both public and private settings. Only registered pharmacists who are members of COSA are eligible for membership of the CPG.
For information on our 2023 CPG events, see the Group Activities
Group information
[Co-Chair] Ms Marissa Ryan, Princess Alexandra Hospital
[Co-Chair] Dr Geeta Sandhu, St Vincent's Hospital Sydney
[Deputy Chair] Ms Kimberley-Ann Kerr, Lyell McEwin Hospital
Mr Chi Hao La, Monash Health
Ms Courtney Oar, Icon Group Pharmacy Services
Ms Katie Wright, NSW Health
Mr Neil Lam, ICON Cancer Care Wesley
Ms Sonia Cuan, Westmead Hospital
Dr Marliese Alexander, Peter MacCallum Cancer Centre
Ms Zainab Reslan, Concord Hospital
Ms Gail Rowan, Peter MacCallum Cancer Centre
Cancer Pharmacists Group Terms of Reference – Council approved 12 November 2018
Read the AGM Minutes from the 14 December 2022
Read the AGM Minutes from the 15 November 2021
Follow and tag @COSACPG
What’s the latest
Group Chairs

Group Chair
Marissa Ryan
Cancer Pharmacists Group Co-Chair

Group Chair
Geeta Sandhu
Cancer Pharmacists Group Co-Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 10 hours ago
RT by @COSAoncology: We can't thank enough all those who helped our team locally: @HNEHealth @UON_research Calvary Mater Newcastle, all our…
Read More >
COSAoncology 11 hours ago
RT by @COSAoncology: Data from recent #cancersurvivorship symposium. We need tools (https://t.co/9CokjAtani) to extend basic psychological c…
Read More >
COSAoncology 3 days ago
RT by @COSAoncology: 🚨1 week left🚨 to submit your expressions of interest to join the @COSAoncology Survivorship Executive Committee. EOI’s…
Read More >
COSAoncology 4 days ago
RT by @COSAoncology: Dr Robyn Brennen’s Clinical Oncology Society of Australia (COSA) poster #2: Adjuvant therapy was associated with increase…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Such an important area of research and applies all over the world. Huge disparities for Australia's First Peoples as wel…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Great opportunity to make a difference in the lives of people with Head & Neck Cancer. #HNCSM #PHD @hncanceraus @Sydney_Uni @Us…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: .@Sabesan68 @profevasegelov @jrzalcberg @COSAoncology @VCCCAlliance @RtnVic @awrccentre @MOGA_ORG #dct
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Hybrid #decentralized #clinicaltrials and #telehealth to improve patient access to trials are coming 💊 Site, sponsor and r…
Read More >
COSAoncology 6 days ago
RT by @COSAoncology: Our @COSAoncology Survivorship Executive Committee is seeking expressions of interest for new members. If you’re a COSA…
Read More >